Apple (AAPL) vs. Eli Lilly (LLY)
This page compares Apple (AAPL) with Eli Lilly (LLY) using performance and risk, profitability, financial strength, growth, dividends, and valuation metrics.
Company Profile
Apple (AAPL) is classified in the Information Technology sector (Technology Hardware & Equipment), whereas Eli Lilly (LLY) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Symbol | AAPL | LLY |
|---|---|---|
| Name | Apple Inc. | Eli Lilly and Company |
| Country/Region | United States | United States |
| GICS Sector | Information Technology | Health Care |
| GICS Industry Group | Technology Hardware & Equipment | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| GICS Sub-Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| Market Capitalization | 4,267.41 billion USD | 1,020.76 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | December 12, 1980 | June 1, 1972 |
| Security Type | Common Stock | Common Stock |
Valuation
Price-to-Earnings Ratio (TTM)
Both Apple (AAPL) at 35.22 and Eli Lilly (LLY) at 40.65 post Price-to-Earnings Ratio (TTM) near the typical industry midpoint — neither company stands out strongly from peers on trailing earnings multiple.
AAPL
Technology Hardware & Equipment industry group
35.22
- Max
- 156.43
- Q3
- 79.96
- Median
- 40.12
- Q1
- 24.19
- Min
- 9.24
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
40.65
- Max
- 86.12
- Q3
- 44.09
- Median
- 25.14
- Q1
- 14.77
- Min
- 1.59
Price-to-Sales Ratio (TTM)
Eli Lilly (LLY) at 14.13 is priced about in line with its industry on Price-to-Sales Ratio (TTM), while Apple (AAPL) at 9.45 sits in the pricier quartile — AAPL costs more per dollar of sales.
AAPL
Technology Hardware & Equipment industry group
9.45
- Max
- 17.39
- Q3
- 8.10
- Median
- 3.66
- Q1
- 1.30
- Min
- 0.00
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
14.13
- Max
- 41.86
- Q3
- 22.86
- Median
- 6.80
- Q1
- 3.35
- Min
- 0.01
Price-to-Book Ratio (MRQ)
Measured against book value, both Apple (AAPL) at 40.02 and Eli Lilly (LLY) at 32.78 look expensive — each Price-to-Book Ratio (MRQ) sits above its industry’s benchmark range.
AAPL
Technology Hardware & Equipment industry group
40.02
- Max
- 17.69
- Q3
- 8.96
- Median
- 4.31
- Q1
- 2.06
- Min
- 0.39
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
32.78
- Max
- 12.97
- Q3
- 6.18
- Median
- 3.45
- Q1
- 1.62
- Min
- -4.60
Valuation at a Glance
| Symbol | AAPL | LLY |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 35.22 | 40.65 |
| Price-to-Sales Ratio (TTM) | 9.45 | 14.13 |
| Price-to-Book Ratio (MRQ) | 40.02 | 32.78 |
| Free Cash Flow Yield | 2.37% | 0.90% |
Profitability
Return on Equity (TTM)
Both Apple (AAPL) at 141.47% and Eli Lilly (LLY) at 107.46% post Return on Equity (TTM) above their industry benchmark ranges, pointing to unusually strong headline returns on shareholders’ equity.
AAPL
Technology Hardware & Equipment industry group
141.47%
- Max
- 44.16%
- Q3
- 18.89%
- Median
- 10.96%
- Q1
- 1.30%
- Min
- -24.11%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
107.46%
- Max
- 100.65%
- Q3
- 3.39%
- Median
- -31.16%
- Q1
- -61.60%
- Min
- -158.89%
Net Profit Margin (TTM)
Eli Lilly (LLY) at 34.99% keeps the most of each sales dollar — above its industry’s Net Profit Margin (TTM) range — and Apple (AAPL) at 27.15% also retains a top-quartile share.
AAPL
Technology Hardware & Equipment industry group
27.15%
- Max
- 30.43%
- Q3
- 12.33%
- Median
- 4.57%
- Q1
- 0.05%
- Min
- -14.09%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
34.99%
- Max
- 13.81%
- Q3
- 4.07%
- Median
- 0.00%
- Q1
- -3.07%
- Min
- -13.58%
Operating Profit Margin (TTM)
Both Apple (AAPL) at 32.28% and Eli Lilly (LLY) at 49.39% squeeze more operating profit from each sales dollar than most peers, ranking in the top Operating Profit Margin (TTM) quartile of their industries.
AAPL
Technology Hardware & Equipment industry group
32.28%
- Max
- 35.67%
- Q3
- 15.31%
- Median
- 6.55%
- Q1
- 1.61%
- Min
- -18.45%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
49.39%
- Max
- 100.30%
- Q3
- 4.94%
- Median
- 0.00%
- Q1
- -133.46%
- Min
- -337.81%
Profitability at a Glance
| Symbol | AAPL | LLY |
|---|---|---|
| Return on Equity (TTM) | 141.47% | 107.46% |
| Return on Assets (TTM) | 26.23% | 20.74% |
| Net Profit Margin (TTM) | 27.15% | 34.99% |
| Operating Profit Margin (TTM) | 32.28% | 49.39% |
| Gross Profit Margin (TTM) | 47.86% | 82.83% |
Growth
Revenue Growth
Revenue Growth at a Glance
| Symbol | AAPL | LLY |
|---|---|---|
| 1-Year Revenue Growth | 6.43% | 44.70% |
| 3-Year Revenue CAGR | 1.81% | 31.69% |
EPS Growth
EPS Growth at a Glance
| Symbol | AAPL | LLY |
|---|---|---|
| 1-Year EPS Growth | 22.70% | 95.99% |
| 3-Year EPS CAGR | 6.88% | 51.71% |
Financial Strength
Current Ratio (MRQ)
Both Apple (AAPL) at 1.07 and Eli Lilly (LLY) at 1.50 run Current Ratio (MRQ) in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
AAPL
Technology Hardware & Equipment industry group
1.07
- Max
- 5.80
- Q3
- 3.18
- Median
- 1.96
- Q1
- 1.31
- Min
- 0.40
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.50
- Max
- 24.81
- Q3
- 11.75
- Median
- 5.47
- Q1
- 2.69
- Min
- 0.23
Debt-to-Equity Ratio (MRQ)
Apple (AAPL) at 0.80 carries Debt-to-Equity Ratio (MRQ) around its industry mid-range, while Eli Lilly (LLY) at 1.39 sits in the higher-leverage quartile.
AAPL
Technology Hardware & Equipment industry group
0.80
- Max
- 2.02
- Q3
- 0.90
- Median
- 0.33
- Q1
- 0.07
- Min
- 0.00
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 1.60
- Q3
- 0.69
- Median
- 0.16
- Q1
- 0.02
- Min
- 0.00
Financial Strength at a Glance
| Symbol | AAPL | LLY |
|---|---|---|
| Current Ratio (MRQ) | 1.07 | 1.50 |
| Debt-to-Equity Ratio (MRQ) | 0.80 | 1.39 |
| Net Debt / EBITDA | 0.10 | 1.05 |
Dividends
Dividend Yield (TTM)
Both Apple (AAPL) at 0.37% and Eli Lilly (LLY) at 0.60% report Dividend Yield (TTM) near their industry mid-ranges, so neither company stands out strongly from peers on cash yield relative to share price.
AAPL
Technology Hardware & Equipment industry group
0.37%
- Max
- 1.41%
- Q3
- 0.59%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.60%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Apple (AAPL) at 12.59% maintains Dividend Payout Ratio (TTM) around its industry median — a balanced dividend policy. Eli Lilly (LLY) at 22.13% sits outside the typical mid-range, leaning toward more retention or more distribution than the industry median.
AAPL
Technology Hardware & Equipment industry group
12.59%
- Max
- 39.42%
- Q3
- 16.33%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
22.13%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividends at a Glance
| Symbol | AAPL | LLY |
|---|---|---|
| Dividend Yield (TTM) | 0.37% | 0.60% |
| Dividend Payout Ratio (TTM) | 12.59% | 22.13% |
Performance & Risk
Performance & Risk at a Glance
| Symbol | AAPL | LLY |
|---|---|---|
| 1-Year Return | 48.46% | 50.32% |
| 1-Year Volatility | 22.41% | 38.24% |
| Beta | 1.09 | 0.51 |
| 3-Month Avg. Volume | 45.47M | 3.15M |